Clinical Trial Update: ATTRACT-52: Primary Care Cardiac Amyloidosis Screening in Ordu, Turkey

View source ↗

Summary

This clinical trial update indicates that ATTRACT-52, a study screening for cardiac amyloidosis due to transthyretin amyloidosis in primary care in Ordu, Turkey…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis
• Transthyretin Amyloidosis

Snippet

Sponsor: Kotyora Family Medicine Health Management and Education Association | Conditions: Cardiac Amyloidosis, Transthyretin Amyloidosis | Status: ENROLLING_BY_INVITATION